Cemented Versus Uncemented Stems in Total Hip Arthroplasty in Patients With Femoral Neck Fractures
Corail-SP Study - A Prospective Randomized Comparison Between Cemented and Uncemented Hydroxyapatite Coated Prosthesis Stems in Total Hip Arthroplasty in Patients With Femoral Neck Fractures
1 other identifier
interventional
109
1 country
1
Brief Summary
The purpose of this prospective randomized study is to compare the quality of treatment between cemented versus uncemented hydroxyapatite coated femoral stems in Total Hip Arthroplasty (THA) in patients who suffers from dislocated femoral neck fractures. Our hypothesis is that an uncemented option spares the patient the operative load of the cementing procedure, i e risk of fatty embolism and inflammatory response, which in turn also perhaps reduces the postoperative cognition strain and improves mobilization parameters. If the uncemented option has the same excellent fixation in poor bone stock, as in the case of these osteopenic fractures, and also has the same good clinical outcome, it would be a viable standard option for the treatment of dislocated femoral neck fractures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 11, 2010
CompletedFirst Submitted
Initial submission to the registry
April 11, 2012
CompletedFirst Posted
Study publicly available on registry
April 17, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 9, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 19, 2020
CompletedSeptember 24, 2020
September 1, 2020
7.8 years
April 11, 2012
September 22, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time to mobilization.
Time (days) to mobilization defined as independent walking with or without walking aids measured by ward physiotherapist with Traffic Light System and Sahlgrenska University Hospital Hip Score (SUHS).
During hospital stay, an expected average of 10 days.
Secondary Outcomes (7)
Cognitive status. Eventual confusion.
During hospital stay, an expected average of 10 days.
Oxygen saturation levels peroperatively.
Peroperatively (during surgery), an expected average of 2 hours.
Bone remodeling around the hip prosthesis.
Postoperatively in average after 2 days. All follow up visits at 3, 6 months, 1, 2, 5, 7, 10 years.
Biomarkers / inflammatory response.
Preoperatively in average 4 hours. Peroperatively at end of wound closure. Postoperatively 1, 3, 5, 7 days. All follow up visits at 3, 6 months, 1, 2, 5, 7, 10 years.
Fixation / migration / loosening of the hip prosthesis components.
Postoperatively in average after 2 days. All follow up visits at 3, 6 months, 1, 2, 5, 7, 10 years.
- +2 more secondary outcomes
Study Arms (2)
Uncemented HA Coated Corail stem
ACTIVE COMPARATORSurgery with an inversed hybrid arthroplasty with an uncemented hydroxyapatite coated Corail stem and a cemented Marathon cup (DePuy).
Cemented Lubinus SPII stem (control arm)
ACTIVE COMPARATORSurgery with a totally cemented option with a Lubinus SPII stem and a IP cup (Link).
Interventions
Cemented Lubinus femoral stem. Cemented IP acetabular cup. (Link).
Uncemented hydroxyapatite coated Corail femoral stem. Cemented Marathon acetabular cup. (DePuy).
Eligibility Criteria
You may qualify if:
- Patients who are acutely admitted to hospital with dislocated femoral neck fractures, that in clinical praxis are in the need of hip prosthesis surgery, are recruited in the study. The fracture shall not engage the lesser nor the greater trochanters.
- Patients who wants to participate in the study and who can consider participation for at least 1 year.
- Coming from independent dwelling conditions.
- Not dementia.
- Circa 60-85 years of age.
- Circa 50 patients in each arm/group shall be included at Mölndal's Hospital (part of Sahlgrenska University Hospital).
You may not qualify if:
- Patients who have difficulties in understanding the intent of the study.
- Rheumatic disorders (RA, Bechterew, SLE).
- Cortison treatment.
- Stroke with remaining weakness or neurological disorders with affection of locomotion.
- Dementia.
- Grave obesity with BMI \>=30-35.
- Delay between time of injury and time of surgery exceeding 72 hours.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sahlgrenska University Hospitallead
- DePuy Orthopaedicscollaborator
Study Sites (1)
Mölndals Hospital (part of Sahlgrenska University Hospital)
Mölndal, 43180, Sweden
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Johan Kärrholm, Prof MD PhD
Orthopaedic Department, Sahlgrenska University Hospital, Gothenburg, SWEDEN
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Physician in Orthopaedic Surgery
Study Record Dates
First Submitted
April 11, 2012
First Posted
April 17, 2012
Study Start
May 11, 2010
Primary Completion
March 9, 2018
Study Completion
February 19, 2020
Last Updated
September 24, 2020
Record last verified: 2020-09